International Journal of Neuropsychopharmacology

Top Research Topics at The International Journal of Neuropsychopharmacology?

The International Journal of Neuropsychopharmacology facilitates discussions on Internal medicine, Endocrinology, Neuroscience, Pharmacology and Psychiatry. The International Journal of Neuropsychopharmacology addresses concerns in Internal medicine which are intertwined with other disciplines, such as Antidepressant, Major depressive disorder, Depression (differential diagnoses) and Schizophrenia. The Schizophrenia research dealing mostly with Antipsychotic is the focus of The International Journal of Neuropsychopharmacology.

The journal facilitates discussions on Endocrinology that incorporate concepts from other fields like Brain-derived neurotrophic factor, Receptor, Anesthesia and Serotonergic. Brain-derived neurotrophic factor studies tackled cover an aspect of the field of Neurotrophic factors. The International Journal of Neuropsychopharmacology connects the study in Neuroscience with the closely related area of Text mining.

Topics in Pharmacology were tackled in line with various other fields like Agonist and Dopamine. It is mostly focused on Dopamine, specifically Dopaminergic. Psychiatry research featured in it incorporates concerns from various other topics such as Placebo, Randomized controlled trial and Clinical psychology.

• Internal medicine (33.25%)
• Endocrinology (23.54%)
• Neuroscience (20.18%)

What are the most cited papers published in the journal?

• Oxidative stress in psychiatric disorders : evidence base and therapeutic implications (745 citations)
• A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. (682 citations)
• A systematic review on reporting and assessment of adverse effects associated with transcranial direct current stimulation (669 citations)

Research areas of the most cited articles at The International Journal of Neuropsychopharmacology:

The published articles investigate areas of study like Internal medicine, Psychiatry, Endocrinology, Neuroscience and Pharmacology. In addition to Internal medicine research, the published articles aim to explore topics under Major depressive disorder, Placebo, Antidepressant and Clinical psychology. The published articles with studies in Psychiatry featured incorporate elements of Tolerability and Randomized controlled trial.

What topics the last edition of the journal is best known for?

• Internal medicine
• Gene
• Enzyme

The previous edition focused in particular on these issues:

The journal investigates areas of study like Internal medicine, Endocrinology, Neuroscience, Schizophrenia and Major depressive disorder. Topics in Internal medicine explored in the journal were investigated in conjunction with research in Placebo, Psychosis, Oncology and Antipsychotic. The close relationship between Prefrontal cortex and Hippocampus is one of the points of interest dissected in Endocrinology research.

It explores issues in Neuroscience which can be linked to other research areas like AMPA receptor and Task (project management). The discussions emphasized the topic of Schizophrenia in an attempt to further explore the field of Psychiatry. The presented research on Major depressive disorder deals specifically with Antidepressant but it also addresses topics in Ketamine.

The most cited articles from the last journal are:

• Evidence-Based Guidelines and Secondary Meta-Analysis for the Use of Transcranial Direct Current Stimulation in Neurological and Psychiatric Disorders. (35 citations)
• Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients With Major Depressive Disorder Who Have Active Suicide Ideation With Intent: Results of a Phase 3, Double-Blind, Randomized Study (ASPIRE II). (23 citations)
• Ketamine and Serotonergic Psychedelics: Common Mechanisms Underlying the Effects of Rapid-Acting Antidepressants. (12 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in The International Journal of Neuropsychopharmacology (based on the number of publications) are:

• Siegfried Kasper (60 papers) published 4 papers at the last edition, 3 less than at the previous edition,
• Toshitaka Nabeshima (26 papers) absent at the last edition,
• Christer Halldin (25 papers) absent at the last edition,
• Pierre Blier (25 papers) published 2 papers at the last edition, 1 more than at the previous edition,
• Klaus-Peter Lesch (24 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in The International Journal of Neuropsychopharmacology (based on the number of publications) are:

• Karolinska Institutet (78 papers) published 2 papers at the last edition the same number as at the previous edition,
• National Institutes of Health (77 papers) published 3 papers at the last edition, 1 more than at the previous edition,
• Harvard University (61 papers) published 2 papers at the last edition, 1 less than at the previous edition,
• Medical University of Vienna (56 papers) published 5 papers at the last edition, 2 less than at the previous edition,
• Centre for Addiction and Mental Health (53 papers) published 4 papers at the last edition, 2 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 3.12% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 24.73% were posted by at least one author from the top 10 institutions publishing in the journal. Another 7.53% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 17.20% of all publications and 50.54% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Prospects for Neuropsychopharmacology Scholars

Another important aspect to consider while discussing the International Journal of Neuropsychopharmacology is understanding the career path available for scholars and researchers in this respective field. Many of these career routes require extensive study and qualifications to practice. For instance, dealing with disorders associated with the brain and behavioral sciences requires a unique set of skills and qualifications. One such demanding profession in this field is a Speech-Language Pathologist in Ohio. These professionals provide treatment for people suffering from communication and swallowing disorders, which can occur as a result of disorders associated with the brain. Becoming a speech-language pathologist requires a master's degree, supervised clinical experience, and state certification. In Ohio, specific licensing requirements need to be met to be a practicing speech-language pathologist. You can learn more about the ohio slp license requirements on our dedicated page. It provides detailed guidelines on the educational qualifications, licensing process, and professional opportunities available in Ohio. Becoming a well-accomplished professional in the field of Neuropsychopharmacology requires both educational prowess and a dedication to the field's improvement. The International Journal of Neuropsychopharmacology provides a platform for sharing vital research that can fuel this career progression and deepen understanding within the discipline.